末梢血管ステント:医療機器パイプライン分析

◆英語タイトル:Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0180
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:286
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Peripheral Vascular Stents – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Peripheral Vascular Stents – Medical Devices Pipeline Assessment, 2019″ provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Vascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripheral Vascular Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Vascular Stents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 8
1.2 List of Figures 13
2 Introduction 14
2.1 Peripheral Vascular Stents Overview 14
3 Products under Development 15
3.1 Peripheral Vascular Stents – Pipeline Products by Stage of Development 15
3.2 Peripheral Vascular Stents – Pipeline Products by Segment 16
3.3 Peripheral Vascular Stents – Pipeline Products by Territory 17
3.4 Peripheral Vascular Stents – Pipeline Products by Regulatory Path 18
3.5 Peripheral Vascular Stents – Pipeline Products by Estimated Approval Date 19
3.6 Peripheral Vascular Stents – Ongoing Clinical Trials 20
4 Peripheral Vascular Stents – Pipeline Products under Development by Companies 21
4.1 Peripheral Vascular Stents Companies – Pipeline Products by Stage of Development 21
4.2 Peripheral Vascular Stents – Pipeline Products by Stage of Development 23
5 Peripheral Vascular Stents Companies and Product Overview 26
5.1 3D Biotek LLC Company Overview 26
5.1.1 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.2 Abbott Vascular Inc Company Overview 27
5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.3 AlviMedica Medical Technologies Inc Company Overview 31
5.3.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.4 AndraTec GmbH Company Overview 38
5.4.1 AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview 38
5.5 Arterius Ltd Company Overview 39
5.5.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
5.6 Boston Scientific Corp Company Overview 40
5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 40
5.7 Cardiatis SA Company Overview 49
5.7.1 Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 49
5.8 Cook Medical Inc Company Overview 50
5.8.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 50
5.9 Cordis Corp Company Overview 54
5.9.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 54
5.10 Corinnova Inc Company Overview 56
5.10.1 Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.11 Cytograft Tissue Engineering Inc (Inactive) Company Overview 57
5.11.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
5.12 Efemoral Medical LLC Company Overview 58
5.12.1 Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.13 Efferent Labs Inc Company Overview 59
5.13.1 Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 59
5.14 Electroformed Stents Inc Company Overview 60
5.14.1 Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.15 Elixir Medical Corp Company Overview 63
5.15.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 63
5.16 FIT Biotech Oy Company Overview 66
5.16.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 66
5.17 ID Nest Medical SAS Company Overview 68
5.17.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 InspireMD Inc Company Overview 69
5.18.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 Intact Vascular LLC Company Overview 70
5.19.1 Intact Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 Kyoto Medical Planning Co Ltd Company Overview 73
5.20.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
6 Peripheral Vascular Stents- Recent Developments 131
6.1 Nov 19, 2019: Data show Zilver PTX leads to fewer complications and shorter hospital stays than traditional bypass surgery 131
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 131
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 133
6.4 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 135
6.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 136
6.6 Nov 07, 2019: Neovasc appoints cardiovascular industry Veteran Bill Little as Chief Operating Officer 136
6.7 Nov 07, 2019: Neovasc announces third quarter 2019 financial results 137
7 Appendix 283
7.1 Methodology 283
7.2 About GlobalData 286
7.3 Contact Us 286
7.4 Disclaimer 286

List of Tables
Table 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development
Table 2: Peripheral Vascular Stents - Pipeline Products by Segment
Table 3: Peripheral Vascular Stents - Pipeline Products by Territory
Table 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path
Table 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
Table 6: Peripheral Vascular Stents - Ongoing Clinical Trials
Table 7: Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
Table 8: Peripheral Vascular Stents - Pipeline Products by Stage of Development
Table 9: 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Status
Table 11: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Description
Table 12: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: ESPRIT Bioresorbable Vascular Scaffold - Product Status
Table 14: ESPRIT Bioresorbable Vascular Scaffold - Product Description
Table 15: ESPRIT BTK Bioresorbable Vascular Scaffold - Product Status
Table 16: ESPRIT BTK Bioresorbable Vascular Scaffold - Product Description
Table 17: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 18: ESPRIT BTK Bioresorbable Vascular Scaffold - Drug Impregnated Bioabsorbable Stent in Asian Population Extremity Arterial Revascularization (DISAPEAR Study)
Table 19: ESPRIT BTK Bioresorbable Vascular Scaffold - Pivotal Investigation of Safety and Efficacy for Bioresorbable Scaffold (BRS) Treatment Below The Knee: LIFE-BTK
Table 20: AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Cre8 BTK - Product Status
Table 22: Cre8 BTK - Product Description
Table 23: Easy Flype - Product Status
Table 24: Easy Flype - Product Description
Table 25: Easy HiFlype - Product Status
Table 26: Easy HiFlype - Product Description
Table 27: Isthmus Logic - Product Status
Table 28: Isthmus Logic - Product Description
Table 29: NiTiDES - Product Status
Table 30: NiTiDES - Product Description
Table 31: AlviMedica Medical Technologies Inc - Ongoing Clinical Trials Overview
Table 32: NiTiDES - Innovative Sirolimus Self Expanding Drug-eluting Stent for the Treatment of Peripheral Disease: Evaluation of Safety and Efficacy. The Illumina Study (Illumina)
Table 33: AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Pillar Bifurcation Reconstruction Device - Product Status
Table 35: Pillar Bifurcation Reconstruction Device - Product Description
Table 36: Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Bioresorbable Stent - Peripheral Vascular Disease - Product Status
Table 38: Bioresorbable Stent - Peripheral Vascular Disease - Product Description
Table 39: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Eluvia Drug-Eluting Vascular Stent System - Product Status
Table 41: Eluvia Drug-Eluting Vascular Stent System - Product Description
Table 42: Gallbladder Drainage System - Product Status
Table 43: Gallbladder Drainage System - Product Description
Table 44: SAVAL Drug Eluting Stent BTK - Product Status
Table 45: SAVAL Drug Eluting Stent BTK - Product Description
Table 46: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Status
Table 47: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Description
Table 48: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 49: Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
Table 50: Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Zilver PTX Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
Table 51: Eluvia Drug-Eluting Vascular Stent System - A Real World Evaluation of the ELUVIA Drug Eluting Stent in All-comers with Superficial Femoral Artery and Proximal Popliteal Artery Disease
Table 52: Eluvia Drug-Eluting Vascular Stent System - Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions
Table 53: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Sinai Vein Stent Registry
Table 54: SAVAL Drug Eluting Stent BTK - A Randomized Trial Comparing the Drug-eluting Stent (DES) Below-the-knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) Versus Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects with Critical Limb Ischemia
Table 55: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Cardiatis FluidSmart 3D Stent - Product Status
Table 57: Cardiatis FluidSmart 3D Stent - Product Description
Table 58: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Zenith Connection Endovascular Covered Stent - Product Status
Table 60: Zenith Connection Endovascular Covered Stent - Product Description
Table 61: Zilver Vena Venous Self-Expanding Stent - Product Status
Table 62: Zilver Vena Venous Self-Expanding Stent - Product Description
Table 63: Cook Medical Inc - Ongoing Clinical Trials Overview
Table 64: Zilver Vena Venous Self-Expanding Stent - Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction
Table 65: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development
Figure 2: Peripheral Vascular Stents - Pipeline Products by Segment
Figure 3: Peripheral Vascular Stents - Pipeline Products by Territory
Figure 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path
Figure 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
Figure 6: Peripheral Vascular Stents - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[末梢血管ステント:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆